Nobuhiko Seki

5.9k total citations
112 papers, 1.7k citations indexed

About

Nobuhiko Seki is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Nobuhiko Seki has authored 112 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Oncology, 44 papers in Pulmonary and Respiratory Medicine and 26 papers in Surgery. Recurrent topics in Nobuhiko Seki's work include Lung Cancer Treatments and Mutations (27 papers), Lung Cancer Research Studies (15 papers) and Asthma and respiratory diseases (13 papers). Nobuhiko Seki is often cited by papers focused on Lung Cancer Treatments and Mutations (27 papers), Lung Cancer Research Studies (15 papers) and Asthma and respiratory diseases (13 papers). Nobuhiko Seki collaborates with scholars based in Japan, China and United States. Nobuhiko Seki's co-authors include Tetsuo Himi, Kenji Eguchi, Hideaki Shirasaki, Takashi Seto, Kazutsugu Uematsu, Megumi Kikuchi, Etsukó Kanaizumi, Takeharu Yamanaka, Fumie Konoeda and Hisashi Uhara and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Nobuhiko Seki

103 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nobuhiko Seki Japan 20 812 525 374 290 227 112 1.7k
Rajesh Malik United States 23 629 0.8× 959 1.8× 648 1.7× 174 0.6× 359 1.6× 88 2.3k
Ahmet Dirican Türkiye 21 577 0.7× 262 0.5× 181 0.5× 171 0.6× 148 0.7× 76 1.3k
Takashi Hirose Japan 21 811 1.0× 713 1.4× 283 0.8× 210 0.7× 158 0.7× 103 1.6k
H. Bier Germany 27 972 1.2× 278 0.5× 591 1.6× 147 0.5× 71 0.3× 108 2.1k
Kazunori Fujitaka Japan 24 565 0.7× 1.1k 2.1× 424 1.1× 182 0.6× 218 1.0× 150 1.9k
Leandro Luongo Matos Brazil 23 511 0.6× 292 0.6× 474 1.3× 173 0.6× 126 0.6× 157 1.9k
Whitfield B. Growdon United States 31 616 0.8× 233 0.4× 545 1.5× 384 1.3× 202 0.9× 139 2.7k
Hayato Yamamoto Japan 26 387 0.5× 738 1.4× 610 1.6× 155 0.5× 130 0.6× 196 2.5k
Masato Karayama Japan 27 422 0.5× 1.3k 2.5× 284 0.8× 443 1.5× 557 2.5× 163 2.2k
Maria Moschovi Greece 23 427 0.5× 219 0.4× 633 1.7× 198 0.7× 89 0.4× 104 1.9k

Countries citing papers authored by Nobuhiko Seki

Since Specialization
Citations

This map shows the geographic impact of Nobuhiko Seki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuhiko Seki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuhiko Seki more than expected).

Fields of papers citing papers by Nobuhiko Seki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobuhiko Seki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuhiko Seki. The network helps show where Nobuhiko Seki may publish in the future.

Co-authorship network of co-authors of Nobuhiko Seki

This figure shows the co-authorship network connecting the top 25 collaborators of Nobuhiko Seki. A scholar is included among the top collaborators of Nobuhiko Seki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobuhiko Seki. Nobuhiko Seki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Luan, Kun, Alfredo Addeo, Raja M. Flores, Nobuhiko Seki, & Ao Liu. (2024). The value of high-risk clinicopathologic features for chemotherapy in stage I non-small cell lung cancer: a propensity score-matched study. Journal of Thoracic Disease. 16(3). 2125–2141. 4 indexed citations
3.
Watanabe, Kiyotaka & Nobuhiko Seki. (2024). Biology and Development of DNA-Targeted Drugs, Focusing on Synthetic Lethality, DNA Repair, and Epigenetic Modifications for Cancer: A Review. International Journal of Molecular Sciences. 25(2). 752–752. 17 indexed citations
4.
5.
Chen, Hao, Masashi Ishihara, Yasuko Ichikawa, et al.. (2024). Efficacy and safety of pharmacotherapy for cancer cachexia: A systematic review and network meta‐analysis. Cancer Medicine. 13(17). e70166–e70166. 4 indexed citations
6.
7.
Yang, Yongjie, Jingli Lü, Jian Kang, et al.. (2021). Evaluation of the reporting quality of clinical practice guidelines on lung cancer using the RIGHT checklist. Translational Lung Cancer Research. 10(6). 2588–2602. 7 indexed citations
8.
Nakahara, Yoshiro, Tsuneo Shimokawa, Naoyuki Nogami, et al.. (2020). Phase I/II study of erlotinib plus S-1 for patients with previously treated non-small cell lung cancer: Thoracic Oncology Research Group (TORG) 0808/0913. Investigational New Drugs. 39(1). 202–209. 2 indexed citations
9.
Ichikawa, Yasuko, Masashi Ishihara, Takahiko Sakamoto, et al.. (2019). Carcinoma of Unknown Primary Site: A Mini-Review on Chemotherapy and the Expectation for Treatment with Nab-Paclitaxel Plus Carboplatin. 2(3). 1 indexed citations
10.
Rizzo, Stefania, Arne Warth, Nobuhiko Seki, et al.. (2017). Pulmonary ground-glass opacity: computed tomography features, histopathology and molecular pathology. Translational Lung Cancer Research. 6(1). 68–75. 60 indexed citations
11.
Seki, Nobuhiko, Jun‐ichi Koizumi, Kenichi Takano, et al.. (2015). A case of progressively transformed germinal center-type IgG4-related lymphadenopathy. Auris Nasus Larynx. 42(4). 345–347. 1 indexed citations
12.
Yamamoto, Tetsuo, et al.. (2014). A Relationship between Birch Pollen Counts and Meteorological Factors in Sapporo. Nippon Jibiinkoka Gakkai Kaiho. 117(5). 653–657. 1 indexed citations
13.
Himi, Tetsuo, et al.. (2013). IgG4-related Disease in the Head and Neck Region. Practica Oto-Rhino-Laryngologica. 106(8). 671–682. 1 indexed citations
14.
Yamamoto, Makoto, et al.. (2012). [Promising new injection method to prevent angialgia/phlebitis from epirubicin hydrochloride therapy for breast cancer].. PubMed. 39(5). 777–81. 1 indexed citations
15.
Inoue, Ken, et al.. (2008). An epidemiological analysis of drunk driving accidents in Kagawa Prefecture – Comparison of 1997–2000 and 2003–2006. Journal of Forensic and Legal Medicine. 15(7). 469–470. 2 indexed citations
16.
Ogasawara, Noriko, Hiroshi Tsubota, Tomoko Shintani, et al.. (2007). Angioleiomyoma of the Left Subcutaneous External Nose. Practica Oto-Rhino-Laryngologica. 100(9). 709–713. 1 indexed citations
17.
Okuyama, Toru, Yoshibumi Nakane, Chiharu Endo, et al.. (2006). Mental health literacy in Japanese cancer patients: ability to recognize depression and preferences of treatments—comparison with Japanese lay public. Psycho-Oncology. 16(9). 834–842. 27 indexed citations
18.
Seki, Nobuhiko, et al.. (2005). Nasopharyngeal Cancer Presented with Repeated Attacks of Syncope. Practica Oto-Rhino-Laryngologica. 98(11). 891–896. 1 indexed citations
19.
Kikuchi, Megumi, et al.. (2005). Two Cases of Olfactory Neuroblastoma. Practica Oto-Rhino-Laryngologica. 98(10). 769–774.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rajesh Malik Breakdown of academic impact, for papers by Ahmet Dirican Breakdown of academic impact, for papers by Takashi Hirose Breakdown of academic impact, for papers by H. Bier Breakdown of academic impact, for papers by Kazunori Fujitaka Breakdown of academic impact, for papers by Leandro Luongo Matos Breakdown of academic impact, for papers by Whitfield B. Growdon Breakdown of academic impact, for papers by Hayato Yamamoto Breakdown of academic impact, for papers by Masato Karayama Breakdown of academic impact, for papers by Maria Moschovi
Rankless by CCL
2026